Cutler Group LLC / CA - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q4 2022$0
-100.0%
1000.0%0.00%
Q3 2022$1,000
-95.7%
100
-87.5%
0.00%
-100.0%
Q2 2022$23,0000.0%800
-55.6%
0.00%0.0%
Q1 2022$23,000
-95.7%
1,800
-97.3%
0.00%
-95.5%
Q4 2021$533,000
+306.9%
67,515
-24.7%
0.02%
+340.0%
Q3 2021$131,000
+129.8%
89,700
+1128.8%
0.01%
+25.0%
Q2 2021$57,000
+256.2%
7,300
+108.0%
0.00%
+300.0%
Q1 2021$16,000
-86.7%
3,510
-2.8%
0.00%
-83.3%
Q4 2020$120,000
+380.0%
3,610
-65.0%
0.01%
+200.0%
Q3 2020$25,000
+47.1%
10,310
+1618.3%
0.00%
+100.0%
Q2 2020$17,000
-60.5%
600
-72.7%
0.00%
-50.0%
Q1 2020$43,000
-80.3%
2,200
-86.1%
0.00%
-84.6%
Q4 2019$218,000
+13.5%
15,800
+32.8%
0.01%
-23.5%
Q3 2019$192,000
-6.3%
11,900
-1.7%
0.02%
-10.5%
Q2 2019$205,000
+0.5%
12,100
+2.5%
0.02%
-9.5%
Q1 2019$204,000
+56.9%
11,800
-48.2%
0.02%
+75.0%
Q4 2018$130,000
-2.3%
22,800
+4.6%
0.01%
+33.3%
Q3 2018$133,000
-40.1%
21,800
-21.7%
0.01%
-47.1%
Q2 2018$222,000
-58.1%
27,840
-33.3%
0.02%
-63.0%
Q1 2018$530,000
+27.4%
41,740
-28.9%
0.05%
+187.5%
Q4 2017$416,000
+137.7%
58,720
+100.7%
0.02%
+128.6%
Q3 2017$175,000
-60.9%
29,251
-66.3%
0.01%
-56.2%
Q2 2017$448,000
+250.0%
86,843
+441.8%
0.02%
+220.0%
Q1 2017$128,000
+3100.0%
16,030
+2190.0%
0.01%
Q3 2016$4,0007000.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q4 2021
NameSharesValueWeighting ↓
Deep Track Capital, LP 7,101,935$55,395,0932.14%
Green Alpha Advisors, LLC 77,188$602,0660.46%
Woodline Partners LP 3,259,710$25,425,7380.30%
TANG CAPITAL MANAGEMENT LLC 200,000$1,560,0000.22%
Spectrum Planning & Advisory Services Inc. 14,038$109,4960.17%
PDT Partners, LLC 156,515$1,220,8170.15%
CALTON & ASSOCIATES, INC. 13,420$104,6760.15%
Corton Capital Inc. 29,365$229,0470.12%
CAXTON ASSOCIATES LP 61,223$477,5390.07%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 119,287$930,4390.06%
View complete list of EDITAS MEDICINE INC shareholders